Literature DB >> 22490869

NLRC5 cooperates with the RFX transcription factor complex to induce MHC class I gene expression.

Torsten B Meissner1, Yuen-Joyce Liu, Kyoung-Hee Lee, Amy Li, Amlan Biswas, Marja C J A van Eggermond, Peter J van den Elsen, Koichi S Kobayashi.   

Abstract

Tight regulation of MHC class I gene expression is critical for CD8 T cell activation and host adaptive-immune responses. The promoters of MHC class I genes contain a well-conserved core module, the W/S-X-Y motif, which assembles a nucleoprotein complex termed MHC enhanceosome. A member of the nucleotide-binding domain, leucine-rich repeat (NLR) protein family, NLRC5, is a newly identified transcriptional regulator of MHC class I genes. NLRC5 associates with and transactivates the proximal promoters of MHC class I genes, although the molecular mechanism of transactivation has not been understood. In this article, we show that NLRC5-mediated MHC class I gene induction requires the W/S and X1, X2 cis-regulatory elements. The transcription factors RFX5, RFXAP, and RFXANK/B, which compose the RFX protein complex and associate with the X1 box, cooperate with NLRC5 for MHC class I expression. Coimmunoprecipitation experiments revealed that NLRC5 specifically interacts with the RFX subunit RFXANK/B via its ankyrin repeats. In addition, we show that NLRC5 can cooperate with ATF1 and the transcriptional coactivators CBP/p300 and general control nonderepressible 5, which display histone acetyltransferase activity. Taken together, our data suggest that NLRC5 participates in an MHC class I-specific enhanceosome, which assembles on the conserved W/S-X-Y core module of the MHC class I proximal promoters, including the RFX factor components and CREB/ATF1 family transcription factors, to promote MHC class I gene expression.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22490869      PMCID: PMC3345046          DOI: 10.4049/jimmunol.1103160

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  51 in total

1.  The S box of major histocompatibility complex class II promoters is a key determinant for recruitment of the transcriptional co-activator CIITA.

Authors:  Annick Muhlethaler-Mottet; Michal Krawczyk; Krzysztof Masternak; Charalambos Spilianakis; Androniki Kretsovali; Joseph Papamatheakis; Walter Reith
Journal:  J Biol Chem       Date:  2004-07-22       Impact factor: 5.157

Review 2.  Virus-lymphoid cell interactions.

Authors:  M B Oldstone
Journal:  Proc Natl Acad Sci U S A       Date:  1996-11-12       Impact factor: 11.205

3.  Induction of MHC class I expression by the MHC class II transactivator CIITA.

Authors:  B K Martin; K C Chin; J C Olsen; C A Skinner; A Dey; K Ozato; J P Ting
Journal:  Immunity       Date:  1997-05       Impact factor: 31.745

4.  Mice lacking the MHC class II transactivator (CIITA) show tissue-specific impairment of MHC class II expression.

Authors:  C H Chang; S Guerder; S C Hong; W van Ewijk; R A Flavell
Journal:  Immunity       Date:  1996-02       Impact factor: 31.745

5.  Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome).

Authors:  V Steimle; L A Otten; M Zufferey; B Mach
Journal:  Cell       Date:  1993-10-08       Impact factor: 41.582

Review 6.  The biochemistry and cell biology of antigen processing and presentation.

Authors:  R N Germain; D H Margulies
Journal:  Annu Rev Immunol       Date:  1993       Impact factor: 28.527

7.  RFXAP, a novel subunit of the RFX DNA binding complex is mutated in MHC class II deficiency.

Authors:  B Durand; P Sperisen; P Emery; E Barras; M Zufferey; B Mach; W Reith
Journal:  EMBO J       Date:  1997-03-03       Impact factor: 11.598

8.  Regulation of MHC class II expression by interferon-gamma mediated by the transactivator gene CIITA.

Authors:  V Steimle; C A Siegrist; A Mottet; B Lisowska-Grospierre; B Mach
Journal:  Science       Date:  1994-07-01       Impact factor: 47.728

Review 9.  Mini-review: Specificity and expression of CIITA, the master regulator of MHC class II genes.

Authors:  Salomé LeibundGut-Landmann; Jean-Marc Waldburger; Michal Krawczyk; Luc A Otten; Tobias Suter; Adriano Fontana; Hans Acha-Orbea; Walter Reith
Journal:  Eur J Immunol       Date:  2004-06       Impact factor: 5.532

10.  A novel DNA-binding regulatory factor is mutated in primary MHC class II deficiency (bare lymphocyte syndrome).

Authors:  V Steimle; B Durand; E Barras; M Zufferey; M R Hadam; B Mach; W Reith
Journal:  Genes Dev       Date:  1995-05-01       Impact factor: 11.361

View more
  66 in total

1.  Post-transcriptional inhibition of luciferase reporter assays by the Nod-like receptor proteins NLRX1 and NLRC3.

Authors:  Arthur Ling; Fraser Soares; David O Croitoru; Ivan Tattoli; Leticia A M Carneiro; Michele Boniotto; Szilvia Benko; Dana J Philpott; Stephen E Girardin
Journal:  J Biol Chem       Date:  2012-06-20       Impact factor: 5.157

Review 2.  NLRC5/CITA: A Key Player in Cancer Immune Surveillance.

Authors:  Sayuri Yoshihama; Saptha Vijayan; Tabasum Sidiq; Koichi S Kobayashi
Journal:  Trends Cancer       Date:  2017-01-10

3.  NLRC5: a NOD-like receptor protein with many faces in immune regulation.

Authors:  Yue Zhao; Feng Shao
Journal:  Cell Res       Date:  2012-05-22       Impact factor: 25.617

4.  An Expanded Role for the RFX Transcription Factor DAF-19, with Dual Functions in Ciliated and Nonciliated Neurons.

Authors:  Elizabeth A De Stasio; Katherine P Mueller; Rosemary J Bauer; Alexander J Hurlburt; Sophie A Bice; Sophie L Scholtz; Prasad Phirke; Debora Sugiaman-Trapman; Loraina A Stinson; Haili B Olson; Savannah L Vogel; Zabdiel Ek-Vazquez; Yagmur Esemen; Jessica Korzynski; Kelsey Wolfe; Bonnie N Arbuckle; He Zhang; Gaelen Lombard-Knapp; Brian P Piasecki; Peter Swoboda
Journal:  Genetics       Date:  2018-01-03       Impact factor: 4.562

5.  NLRC5/MHC class I transactivator is a target for immune evasion in cancer.

Authors:  Sayuri Yoshihama; Jason Roszik; Isaac Downs; Torsten B Meissner; Saptha Vijayan; Bjoern Chapuy; Tabasum Sidiq; Margaret A Shipp; Gregory A Lizee; Koichi S Kobayashi
Journal:  Proc Natl Acad Sci U S A       Date:  2016-05-09       Impact factor: 11.205

6.  Dynamic Role of trans Regulation of Gene Expression in Relation to Complex Traits.

Authors:  Chen Yao; Roby Joehanes; Andrew D Johnson; Tianxiao Huan; Chunyu Liu; Jane E Freedman; Peter J Munson; David E Hill; Marc Vidal; Daniel Levy
Journal:  Am J Hum Genet       Date:  2017-03-09       Impact factor: 11.025

Review 7.  Biological Consequences of MHC-II Expression by Tumor Cells in Cancer.

Authors:  Margaret L Axelrod; Rebecca S Cook; Douglas B Johnson; Justin M Balko
Journal:  Clin Cancer Res       Date:  2018-11-21       Impact factor: 12.531

8.  Respiratory Syncytial Virus Infection Upregulates NLRC5 and Major Histocompatibility Complex Class I Expression through RIG-I Induction in Airway Epithelial Cells.

Authors:  Xuancheng Guo; Taixiang Liu; Hengfei Shi; Jingjing Wang; Ping Ji; Hongwei Wang; Yayi Hou; Ren Xiang Tan; Erguang Li
Journal:  J Virol       Date:  2015-05-13       Impact factor: 5.103

9.  A genetic variant in the placenta-derived MHC class I chain-related gene A increases the risk of preterm birth in a Chinese population.

Authors:  Junjiao Song; Jing Li; Han Liu; Yuexin Gan; Yang Sun; Min Yu; Yongjun Zhang; Fei Luo; Ying Tian; Weiye Wang; Jun Zhang; Julian Little; Haidong Cheng; Dan Chen
Journal:  Hum Genet       Date:  2017-09-01       Impact factor: 4.132

Review 10.  Class I transactivator, NLRC5: a central player in the MHC class I pathway and cancer immune surveillance.

Authors:  Saptha Vijayan; Tabasum Sidiq; Suhail Yousuf; Peter J van den Elsen; Koichi S Kobayashi
Journal:  Immunogenetics       Date:  2019-01-31       Impact factor: 2.846

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.